TY  - GEN
AU  - Shin,Ho Cheol
AU  - Seo,Jongwon
AU  - Kang,Byung Woog
AU  - Moon,Joon Ho
AU  - Chae,Yee Soo
AU  - Lee,Soo Jung
AU  - Lee,Yoo Jin
AU  - Han,Seoae
AU  - Seo,Sang Kyung
AU  - Kim,Jong Gwang
AU  - Sohn,Sang Kyun
AU  - Park,Tae-In
TI  - Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy
SN  - 2005-6648
PY  - 2015///0814
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Chi-Square Distribution
KW  - Cyclophosphamide
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Immunohistochemistry
KW  - Kaplan-Meier Estimate
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - chemistry
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - NF-kappa B
KW  - Neoplasm Staging
KW  - Predictive Value of Tests
KW  - Prednisone
KW  - Proportional Hazards Models
KW  - Receptors, CXCR4
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Rituximab
KW  - Time Factors
KW  - Treatment Outcome
KW  - Vincristine
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3904/kjim.2014.29.6.785
ER  -